AAOS Now, October 2022
-
The Presence or Lack of Psychological Safety in Surgery Directly Impacts Team Member Morale and Patient Care
Orthopaedic surgeons can improve psychological safety in their practices by cultivating skills in three focus areas: communication, conflict, and culture.
-
AAOS Board of Directors Approves CPG for the Management of ACL Injuries and Two AUC Reissues
The AAOS Board of Directors (BoD) approved an update to the 2014 AAOS Clinical Practice Guideline (CPG) for the Management of Anterior Cruciate Ligament (ACL) Injuries and the reissues of two Appropriate Use Criteria (AUC) for the Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: one intended for use by general pediatricians and referring physicians and the second intended for use by orthopaedic surgeons.
-
AAOS Registries Are a Path to Aetna Institutes of Quality ® Designation
An orthopaedic program is challenged to stand out when patients have numerous options for their care. Quality certifications and payer distinction designations may be influencing factors but can be burdensome to attain.
-
AAOS to Host Second Annual Biologics Symposium
This year, AAOS will host its second annual biologics symposium, titled “The Next Generation of Biologics: Use of Real-world Evidence,” in Washington, D.C. It is designed to convene experts in science and medicine, industry, as well as regulatory agencies to examine current real-world evidence as it pertains to musculoskeletal medicine.
-
ICL Elucidates Regulatory Guidelines on Orthobiologics
Scott Bruder, MD, PhD, founder and CEO of Bruder Consulting & Venture Group, was the first presenter in the Instructional Course Lecture (ICL) titled “Orthobiologics Use and Marketing: U.S. Food and Drug Administration, Federal Trade Commission, and Ethical Compliance,” which discussed the complex regulations surrounding the use of orthobiologics.